A systematic analysis of anti-diabetic medicinal plants from cells to clinical trials.

Background: Diabetes is one of the fastest-growing health emergencies of the 21 century, placing a severe economic burden on many countries. Current management approaches have improved diabetic care, but several limitations still exist, such as decreased efficacy, adverse effects, and the high cost of treatment, particularly for developing nations. There is, therefore, a need for more cost-effective therapies for diabetes management.

Protective effect of carvedilol alone and coadministered with diltiazem and prednisolone on doxorubicin and 5-fluorouracil-induced hepatotoxicity and nephrotoxicity in rats.

This study investigated the protective effects of carvedilol alone and coadministered with prednisolone and diltiazem on doxorubicin (DOX) and 5-fluorouracil (5-FU)-induced toxicity. Each of 2 pools of 70 female rats were randomly allotted into 10 groups of 7 animals each and treated as follows: Group 1: normal saline (10 mL/kg); Group 2: normal saline and DOX (40 mg/kg)/5-FU (20 mg/kg) alone; Group 3: gallic acid (200 mg/kg) and DOX/5-FU; Group 4: carvedilol (0.075 mg/kg) and DOX/5-FU; Group 5: carvedilol (0.

Methionine and vitamin B-complex ameliorate antitubercular drugs-induced toxicity in exposed patients.

Tuberculosis therapy utilizes drugs that while effective cause treatment-related toxicity. Modulation of antitubercular drugs-induced toxicity by methionine and vitamin B-complex in patients was evaluated. 285 treatment-naïve tuberculosis patients at the Chest Clinics of Infectious Diseases Hospital, Yaba and General Hospital, Lagos in Lagos, Nigeria was prospectively recruited and allotted into test (antitubercular medicines, methionine and vitamin B-complex) and control groups (antitubercular medicines).

Toxicological evaluation of the aqueous stem bark extract of Bridelia ferruginea (Euphorbiaceae) in rodents.

Bridelia ferruginea is a woody shrub that grows in the Savannah or rain forests of Africa and has traditionally been used to treat diabetes, arthritis and boils. Despite all these uses, extensive toxicological evaluation has not been carried out. The aim of the present investigation was to evaluate the sub-chronic toxicological effects of the stem bark aqueous extract of Bridelia ferruginea in rats.

Gentamicin nephrotoxicity: Animal experimental correlate with human pharmacovigilance outcome.

Background: National Agency for Food and Drugs Administration and Control (NAFDAC), which is responsible for pharmacovigilance activity in Nigeria, recently withdrew injection gentamicin 280 mg, used in the management of life-threatening and multidrug-resistant infections from circulation, due to reported toxicity. Thus, this study aimed to investigate the toxicity profile of the commonly used strengths (80 mg and 280 mg) of gentamicin on kidney using animal models.

Methods: Animals were divided into five groups of 16 rats each.

Safety of herbal medicines use: case study of ikorodu residents in Lagos, Nigeria.

Background: Despite the reported widespread use of herbal medicines globally and their benefits, they are not completely without potential to cause harm. The haphazard, irresponsible or non-regulated use of several herbal medicines may put the health of their users at risk of toxicity.

Objective: This study aimed to assess the general perception of the safety and occurrence of adverse effects of herbal medicines among residents of Ikorodu in Lagos, Nigeria.

Traditional medicine policy and regulation in Nigeria: an index of herbal medicine safety.

Background: The requirements and methods for research and evaluation of the safety and efficacy of herbal medicines are more complex than those for conventional pharmaceuticals. In addition to the aforementioned and contrary to the general belief that herbal medicines are safe and despite the profound therapeutic advantages possessed by medicinal plants, some of their constituents have been shown to be potentially toxic, carcinogenic, mutagenic, and teratogenic. Thus, traditional medicine policy and regulation have been made an integral part of the WHO proposed critical determinants of herbal medicine safety.